13-valent pneumococcal conjugate vaccine use in children 6 through 18 years of age with immunocompromising conditions : GRADE of evidence
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i


13-valent pneumococcal conjugate vaccine use in children 6 through 18 years of age with immunocompromising conditions : GRADE of evidence
Filetype[PDF-294.89 KB]


Details:
  • Supporting Files:
    No Additional Files

You May Also Like: